CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962)

Authors :: Catherine Myers
Kathlyn Lim
Reiad Najjar
Noriko Ammerman
Edmund Huang
Ashley Vo
Stanley C. Jordan
Summer Williamson
Mieko Toyoda
Alice Peng
Shili Ge
Jua Choi
Supreet Sethi
Source :: Transplantation. 104:S104-S105
Publication Year :: 2020
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2020.

Subjects :: Transplantation
Clazakizumab
business.industry
medicine.medical_treatment
Immunology
Medicine
Anti-IL-6
Human leukocyte antigen
business
Kidney transplant
Desensitization (medicine)

Full Text Access

Tools